drugset / Trial / NCT00212381
Oral Diindolylmethane (DIM) for the Treatment of Cervical Dysplasia
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To determine if the use of oral Diindolylmethante (DIM), a marketed cruciferous vegetable based dietary supplement (Bioresponse-DIM), is associated with the regression of cervical dysplasia in otherwise healthy women.
Timeline
- Start
- 2000-09
- Primary completion
- 2006-01
- Completion
- 2010-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ARUNDINE | Small molecule | 2 mg/kg | Oral |